Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > This is trading
View:
Post by bigmack1 on Mar 10, 2021 10:47am

This is trading

Just like a stock would trade with a serious NR in their back pocket. I think we will see some very feeble tree shaking for the next 4 -10 trading days. 

this stock is so tightly wound that the slightest gust of wind will send us north of $7.00...

if I was a rookie investor, I would look myself in eye and say. Dude. Hang on to your shares and walk away for a month. Don't watch. Just find something nice to do like long walks and mint tea. 


come back later and harvest. 


(Not to be taken as advice). Just a thought from someone who has seen this before.

Comment by 3burtc on Mar 10, 2021 11:14am
Oh oh spaghettios. Hard to believe that real shareholders don't want a higher share price! Oh I see!
Comment by YukonJezza on Mar 10, 2021 11:57am
Huh. ?????
Comment by 3burtc on Mar 10, 2021 12:08pm
It's so laughable that the stock trades based on what's posted on stockhouse. You clones will never convince retail investors to sell if you don't clean up your act. Cheers!
Comment by Layth1990 on Mar 10, 2021 12:12pm
well institutional investors from last deal dumped retaill investors like me and you. thanks to Dan!  i sold 10k shares around 5+ and will clear all very soon on 5cad. we are getting used here!
Comment by 3burtc on Mar 10, 2021 12:15pm
Oh okay.
Comment by Miso420 on Mar 10, 2021 12:22pm
paper handed baby
Comment by 3burtc on Mar 10, 2021 12:29pm
Okay, I'll leave you institutional guys alone. Have a nice day everyone!
Comment by Beanie28 on Mar 10, 2021 12:52pm
bra you sound like some one who bought in above $6 it's ok we still love and accept you for who you are
Comment by Notthatbright on Mar 10, 2021 12:56pm
What the point of your post...Many bought over $7.00 what business is it of yours!
Comment by Beanie28 on Mar 10, 2021 1:11pm
your name is fitting. Read it and try again buddy
Comment by Notthatbright on Mar 10, 2021 1:17pm
LOL, almost as funny as BEANIE Baby.  We all in the same boat paddling upstream it seems.  GL
Comment by SunsetGrill on Mar 10, 2021 12:29pm
How do you know that? Oh and see ya (I would take your shares at 5 but I can get them at 4.75) - You  dont have the patience (or conficence) to buy 20% below a 35 million dollar raise. Seems like a deal to me but what do i know. To me it seems apparent that besides Phase III not meeting endpoint risk - The issue with the malaise is the extended time line to find out - 2023 is it?? That ...more  
Comment by HarveyTwoface on Mar 10, 2021 3:58pm
I will definitely stick around with as many shares as possible at these prices because this will easily go 100% - 300% once licensing deal for EU or US are announced. Big Pharma will buy this long before any p3 results. There are still other drugs in ATE pipeline to develop too. Keep your shares because shorting also serves those who are here to accumulate, and you don't know who's buying ...more  
Comment by SunsetGrill on Mar 10, 2021 5:49pm
Ahhh Whaa?  Big Phara employee #1 "hey J.R. im gonna spend a few hundred million on a flyer before P3 completed" Pfizer prez: "here is a blank check I authorize  up to a billion" P3 fails - Oh well Doesnt quite work that way in the pharma world
Comment by WalkOverTheStrt on Mar 10, 2021 11:32pm
@Sunset - inccorect. BP has done this in the past for mid to later stage biotechs for $1b +  here is a few from five minutes of google seach PH1 for over $1B https://www.biopharmadive.com/news/merck-pandion-deal-negotiations-pricey-buyout/596216/ PH2 buyout $1.9B https://www.biopharmadive.com/news/amgen-five-prime-cancer-drug-deal-acquisition/596124/ That drug, bemarituzumab, has been ...more  
Comment by SunsetGrill on Mar 11, 2021 9:46am
Well OBVIOUSLY thats what I meant - that takeouts NEVER happen before P III complettion - Cmon read between the lines just a little teeny bit. Its hightly unlikely (and you cant hope for) a buyout prior to phase III competion (hows that !!)
Comment by Marky1 on Mar 11, 2021 10:31am
That's simply not true! Look at AskBio....Taken out by Bayer for 4BUSD and haven't even finished P1 testing
Comment by HarveyTwoface on Mar 11, 2021 4:12am
Mm, I am sure you are right because you know everything. Wow.
Antibe Therapeutics Inc(Pre-Merger)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities